Latest From Biotech Now

BIO Celebrates National Rice Month with Golden Rice!

Golden Rice

September is National Rice Month! To celebrate, BIO wanted to to highlight the amazing and lifesaving biofortified crop, Golden Rice. Golden Rice is a genetically modified rice plant that produces and accumulates provitamin A (β-carotene) in the grain, something that doesn’t happen in naturally occurring rice plants. According to UNICEF, the estimated number of children deaths precipitated worldwide by vitamin A deficiency (VAD) every year lies at 1.15 million. Many more show VAD-related syndromes, among them loss of sight Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , ,

What if We Could Stop E. Coli at the Source?

E. Coli

According to a recent article in Food Safety News, Scientists have found out that genetically engineered plants can produce proteins able to reduce E. Coli on food. In a study published earlier this month in the Proceedings of the National Academy of Sciences, the team engineered tobacco, leafy beets, spinach, chicory and lettuce to produce colicins. The research team, led by scientists from two German biotech companies, Nomad Bioscience and Icon Genetics, found that certain plants, such as tobacco, can Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Investment Landscape in Brazil

Rio de Janeiro, Brazil

Brazil has been at the forefront of biotech news recently, with China announcing plans to invest $250B and the recently signed Joint Communique with the U.S. government reaffirming their commitment to strengthening traditional ties, expand trade, and investment cooperation. Brazil is now one of the most attractive and promising biotech markets in the world—human health, agribusiness, raw materials and environmental—and investing in Brazil has become a new priority. Rather than leave innovation financing solely to Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

FOIA Attacks Against Biotech Scientists Get Personal

Alison Van Eenennaam

Much has been written and discussed online about the relationships between independent researchers and industry groups.  New York Times reporter Eric Lipton wrote about this in a detailed September 5 article, “Food Industry Enlisted Academics in GMO Lobbying War, Emails Show”. Lipton’s article comes about 6 months after U.S. Right to Know (USRTK) filed FOIA requests for emails and documents of more than forty public university faculty and staff members seeking to link these individuals Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Reality Check for AHIP: Competition Driving Down Costs for Hepatitis C Meds


Yesterday at a House Judiciary Committee hearing on competition in the healthcare marketplace, AHIP Executive Vice President Daniel Durham took the occasion to bemoan what he termed “monopoly pricing” in the pharmaceutical industry. He proceeded to cite the cost of two new specialty medicines for Hepatitis C, Gilead Sciences’ Sovaldi and Harvoni, as a “case study” of that problematic monopoly pricing. Durham’s analysis suffers from a particularly egregious flaw: Gilead and its products do not enjoy Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,